On the product side, we use clinical blind studies & consumer test paneling, MedGen's products seek approval from both health professionals & the general public. We believe studied introductions are important & have spent hundreds of thousands of dollars in R & D to date. We are dedicated to the health and wellness of all & as our top No. 1 priority we will continue to invest heavily in future research for sustained health development.
On the Financial Services side, management has put to good use its previous experience in the Investment Banking, Public Banking and better than 45 years of experience in the management of publicly traded companies and building “start-up” companies. In 2007 this division earned better than $1.2 million, which was used to fortify the marketing effort of its products division.
While the overriding vision of management is growing a significant and large company producing OTC health related products, our ability to become multi-faceted, uniquely mobile in the business model and multi-directional in seeking opportunities for growth, will eventually pay-off, much like the giants (GE, GM, Ford,) that sprang up during the depression years. These companies’s now have divisions that stretch far from their original plan. Many have Financial Divisions and Capital Investment Funds as a way of furthering their overall profitability and enhancing the salability of their products. In many cases, it is the financial divisions that support the manufacturing effort.
What defines our company is the complexity of our perceptions; our unique vision. This is the sum of our collective experience in business and in life. It is this force that has propelled us and kept us afloat for the past 11 years and it will, no doubt, propel us to greatness in the future.
Paul B. Kravitz
Chairman & Chief Executive Officer